EP 3554527 A1 20191023 - SALINE FORMULATIONS OF SPLUNC1 PEPTIDES
Title (en)
SALINE FORMULATIONS OF SPLUNC1 PEPTIDES
Title (de)
SALZHALTIGE FORMULIERUNGEN VON SPLUNC1-PEPTIDEN
Title (fr)
PRÉPARATIONS SALINES DE PEPTIDES SPLUNC1
Publication
Application
Priority
- US 201662433549 P 20161213
- US 2017065862 W 20171212
Abstract (en)
[origin: WO2018111903A1] The present invention relates to pharmaceutical formulations of non-naturally occurring peptides to bind to sodium channels and inhibit activation of the sodium channels. The invention further relates to methods for regulating of sodium absorption and fluid volume and treating disorders responsive to modulating sodium absorption by modulating the binding of specialized non-naturally occurring peptides to sodium channels.
IPC 8 full level
A61K 38/08 (2019.01); A61K 9/00 (2006.01); A61K 33/14 (2006.01); A61P 11/00 (2006.01); A61P 11/12 (2006.01); C07K 7/06 (2006.01)
CPC (source: EP US)
A61K 9/0078 (2013.01 - EP); A61K 38/08 (2013.01 - EP US); A61P 11/00 (2017.12 - EP); A61P 11/12 (2017.12 - EP); C07K 7/06 (2013.01 - EP); C07K 7/08 (2013.01 - EP)
Citation (search report)
See references of WO 2018111903A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018111903 A1 20180621; CA 3046361 A1 20180621; EP 3554527 A1 20191023
DOCDB simple family (application)
US 2017065862 W 20171212; CA 3046361 A 20171212; EP 17832396 A 20171212